# Sativa Wellness Group Novel food application significant milestone

- Link: https://www.directorstalkinterviews.com/sativa-wellness-group-novel-food-application-significant-milestone/412960973
- Published: 2021-02-15T07:06:48+00:00
- Author: Giles

**Sativa Wellness Group plc** (LON:SWEL) has announced that it has submitted its
Novel Food application for validation by the Food Standards Agency (“FSA”) ahead
of the 31 March 2021 deadline, as part of the Company’s ongoing commitment to continually
deliver the highest level of regulatory compliance and product quality – ‘CBD you
can trust’.  

The submission, led by award winning Life Sciences Regulatory and Quality Compliance
consultancy, Global Regulatory Services and supported by Group’s in-house team of
scientist and quality/compliance professionals, incorporates an extensive array 
of products under its Goodbody brands and on behalf of white label customers. Products
include oil-based food supplements, gummies, soft gel capsules and sports recovery
gels, as well as wholesale bulk CBD ingredients.

Further to the Company’s press release dated 25 September 2020, Sativa is also a
member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium
and its landmark toxicology study, providing the necessary safety data required 
by the FSA.

The Company plans to submit the same application to the European Food Safety Authority,
once it has collated the pre-requisite consumer product stability, toxicology and
genotox data.

> **Geremy Thomas, Sativa Wellness Executive Chairman, said:** “This is a significant
> milestone for the Company. The CBD market is likely to consolidate around the 
> major players that put product quality and regulatory compliance at the forefront.
> Sales channels in the UK will open up and smaller players will likely fall away”.

Share on:
